Brought to you by 
US Genomics closes $25mm third round, then additional $7mm
02 Nov 2004
Executive Summary
US Genomics (single-molecule analysis technologies) grossed $25mm with a third-round private placement to Fidelity Biosciences Group (which led the financing) and new investors Zero Stage Capital and China Development Industrial Bank. Existing investors HealthCare Ventures and CB Health Ventures also participated.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
US Genomics closes $25mm third round, then additional $7mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice